First experience in proteasome inhibitor therapy of dedifferentiated, radioiodine negative, somatostatin- receptor negative thyroid cancer

被引：0
|
作者：
Putzer, Daniel [1 ]
Gabriel, Michael [1 ]
Eisterer, Wolfgang [2 ]
Kendler, Dorota [1 ]
Prommegger, Rupert [3 ]
Madleitner, Ruth [1 ]
Dobrozemsky, Georg [1 ]
Gastl, Guenther [2 ]
Virgolini, Irene [1 ]
机构：
[1] Innsbruck Med Univ, Dept Nucl Med, Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria
[3] Innsbruck Med Univ, Dept Surg, Innsbruck, Austria
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1667
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
    Arielle L. Heeke
    Antoinette R. Tan
    [J]. Cancer and Metastasis Reviews, 2021, 40 : 537 - 547
  • [42] Targeting thyroid hormone receptor beta in triple-negative breast cancer
    Gu, Guowei
    Gelsomino, Luca
    Covington, Kyle R.
    Beyer, Amanda R.
    Wang, John
    Rechoum, Yassine
    Huffman, Kenneth
    Carstens, Ryan
    Ando, Sebastiano
    Fuqua, Suzanne A. W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 535 - 545
  • [43] Targeting thyroid hormone receptor beta in triple-negative breast cancer
    Guowei Gu
    Luca Gelsomino
    Kyle R. Covington
    Amanda R. Beyer
    John Wang
    Yassine Rechoum
    Kenneth Huffman
    Ryan Carstens
    Sebastiano Andò
    Suzanne A. W. Fuqua
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 535 - 545
  • [44] 201Tl SPECT substantially improves detectability of radioiodine-negative metastatic thyroid cancer.
    Nakada, K
    Takei, T
    Suginami, Y
    Shiga, T
    Kaji, T
    Morota, K
    Katoh, C
    Tasukamoto, E
    Tamaki, N
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 322P - 322P
  • [45] Rosiglitazone in two patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer:: preliminary results
    Martin, Tomas
    Torres, Alberto
    Cambil, Teresa
    Castro, Juan
    [J]. MEDICINA CLINICA, 2008, 131 (11): : 435 - 435
  • [46] A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer
    Kebebew, Electron
    Peng, Miao
    Reiff, Emily
    Treseler, Patrick
    Woeber, Kenneth A.
    Clark, Orlo H.
    Greenspan, Francis S.
    Lindsay, Sheila
    Duh, Quan-Yang
    Morita, Eugene
    [J]. SURGERY, 2006, 140 (06) : 960 - 966
  • [47] GLPG1790: The first Ephrin (EPH) receptor tyrosine kinase inhibitor for the treatment of triple negative breast cancer
    Pujuguet, Philippe
    Beirinckx, Filip
    Delachaume, Carole
    Huck, Jacques
    Van der Aar, Ellen
    Brys, Reginald
    Van Rompaey, Luc
    Wigerinck, Piet
    Saniere, Laurent
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [48] Our first experience with low dose radioiodine ablation Therapy in low risk patients with differentiated thyroid carcinoma
    Rajkovaca, Z.
    Mijatovic, J.
    Skrobic, M.
    Mikac, G.
    Vuleta, G.
    Matavulj, A.
    Kovacevic, P.
    Ponorac, N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S356 - S356
  • [49] A new hormonal therapy for estrogen receptor-negative breast cancer
    Hardin, Chelsea
    Pommier, Rodney
    Calhoun, Kristine
    Muller, Patrick
    Jackson, Terisa
    Pommier, SuEllen
    [J]. WORLD JOURNAL OF SURGERY, 2007, 31 (05) : 1041 - 1046
  • [50] Advances in preventive therapy for estrogen-receptor-negative breast cancer
    Litzenburger B.C.
    Brown P.H.
    [J]. Current Breast Cancer Reports, 2014, 6 (2) : 96 - 109
12345